Research

Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042499/

Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094865/

18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968877/

Severe relapse of anti-NMDA receptor encephalitis 5 years after initial symptom onset February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661405/

Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531245/

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537134/

Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398345/